Deficiency of regulatory B cells increases allergic airway inflammation

Inflammation Research

Volumn 54, Issue 12, 2005, Pages 514-521

  Lundy, S K ^a   Berlin, A A ^a   Martens, T F ^a   Lukacs, N W ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

Allergy; Apoptosis; B cells; Inflammation; T cells

Indexed keywords

ALLERGEN; CD4 ANTIGEN; GAMMA INTERFERON; IMMUNOGLOBULIN E; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 5; MESSENGER RNA; RANTES;

AIRWAY; ALLERGIC DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY BLOOD LEVEL; APOPTOSIS; ARTICLE; B LYMPHOCYTE; BLOOD SAMPLING; COCKROACH; CONTROLLED STUDY; CYTOKINE PRODUCTION; EOSINOPHILIA; FEMALE; HISTOLOGY; IMMUNE DEFICIENCY; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOPATHOGENESIS; IN VITRO STUDY; INSECT ALLERGY; LUNG HOMOGENATE; LYMPH NODE CELL; MOUSE; MUCOSA INFLAMMATION; NONHUMAN; PNEUMONIA; RESPIRATORY TRACT INFLAMMATION; SENSITIZATION; T LYMPHOCYTE; X CHROMOSOME LINKED DISORDER;

ANIMALS; ANTIGENS, CD4; ANTIGENS, CD5; APOPTOSIS; ASTHMA; B-LYMPHOCYTES; CD4 LYMPHOCYTE COUNT; CD4-POSITIVE T-LYMPHOCYTES; COCKROACHES; CYTOKINES; DISEASE MODELS, ANIMAL; FAS LIGAND PROTEIN; FEMALE; GENE EXPRESSION REGULATION; HYPERSENSITIVITY; IMMUNOGLOBULIN E; LUNG; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED CBA; MICE, MUTANT STRAINS; RANTES; TUMOR NECROSIS FACTORS;

EID: 29944440185     PISSN: 10233830     EISSN: 1420908X     Source Type: Journal    
DOI: 10.1007/s00011-005-1387-0     Document Type: Article

References (53)

1. Taube C, Dakhama A, Gelfand EW. Insights into the pathogenesis of asthma utilizing murine models. Int Arch Allergy Immunol 2004; 135: 173-86.
2. Ngoc PL, Gold DR, Tzianabos AO, Weiss ST, Celedon JC. Cytokines, allergy, and asthma. Curr Opin Allergy Clin Immunol 2005; 5: 161-6.
3. Kuipers H, Lambrecht BN. The interplay of dendritic cells, Th2 cells and regulatory T cells in asthma. Curr Opin Immunol 2004; 16: 702-8.
4. Wills-Karp M. Immunologic basis of antigen-induced airway hyperresponsiveness. Annu Rev Immunol 1999; 17: 255-81.
5. Romagnani S. Cytokines and chemoattractants in allergic inflammation. Mol Immunol 2002; 38: 881-5.
6. Finkelman FD, Katona IM, Urban JF, Jr., Holmes J, Ohara J, Tung AS, et al. IL-4 is required to generate and sustain in vivo IgE responses. J Immunol 1988; 141: 2335-41.
7. D'Andrea A, Ma X, Aste-Amezaga M, Paganin C, Trinchieri G. Stimulatory and inhibitory effects of interleukin (IL)-4 and IL-13 on the production of cytokines by human peripheral blood mononuclear cells: priming for IL-12 and tumor necrosis factor alpha production. J Exp Med 1995; 181: 537-46.
8. Rankin JA, Picarella DE, Geba GP, Temann UA, Prasad B, DiCosmo B, et al. Phenotypic and physiologic characterization of transgenic mice expressing interleukin 4 in the lung: lymphocytic and eosinophilic inflammation without airway hyperreactivity. Proc Natl Acad Sci U S A 1996; 93: 7821-5.
9. Shimoda K, van Deursen J, Sangster MY, Sarawar SR, Carson RT, Tripp RA, et al. Lack of IL-4-induced Th2 response and IgE class switching in mice with disrupted Stat6 gene. Nature 1996; 380: 630-3.
10. Grunewald SM, Werthmann A, Schnarr B, Klein CE, Brocker EB, Mohrs M, et al. An antagonistic IL-4 mutant prevents type I allergy in the mouse: inhibition of the IL-4/IL-13 receptor system completely abrogates humoral immune response to allergen and development of allergic symptoms in vivo. J Immunol 1998; 160: 4004-9.
11. Holgate ST, Hardy C, Robinson C, Agius RM, Howarth PH. The mast cell as a primary effector cell in the pathogenesis of asthma. J Allergy Clin Immunol 1986; 77: 274-82.
12. Holgate ST. The role of mast cells and basophils in inflammation. Clin Exp Allergy 2000; 30 Suppl 1: 28-32.
13. Pawankar R, Yamagishi S, Takizawa R, Yagi T. Mast cell-IgE-and mast cell-structural cell interactions in allergic airway disease. Curr Drug Targets Inflamm Allergy 2003; 2: 303-12.
14. Campbell HD, Sanderson CJ, Wang Y, Hort Y, Martinson ME. Tucker WQ, et al. Isolation, structure and expression of cDNA and genomic clones for murine eosinophil differentiation factor. Comparison with other eosinophilopoietic lymphokines and identity with interleukin-5. Eur J Biochem 1988; 174: 345-52.
15. Grunig G, Warnock M, Wakil AE, Venkayya R, Brombacher F, Rennick DM, et al. Requirement for IL-13 independently of IL-4 in experimental asthma. Science 1998; 282: 2261-3.
16. Zhu Z, Homer RJ, Wang Z, Chen Q, Geba GP, Wang J, et al. Pulmonary expression of interleukin-13 causes inflammation, mucus hypersecretion, subepithelial fibrosis, physiologic abnormalities, and eotaxin production. J Clin Invest 1999; 103: 779-88.
17. Blease K, Jakubzick C, Westwick J, Lukacs N, Kunkel SL, Hogaboam CM. Therapeutic effect of IL-13 immunoneutralization during chronic experimental fungal asthma. J Immunol 2001; 166: 5219-24.
18. Lukacs NW. Role of chemokines in the pathogenesis of asthma. Nat Rev Immunol 2001; 1: 108-16.
19. Vignola AM, Chanez P, Chiappara G, Siena L, Merendino A, Reina C, et al. Evaluation of apoptosis of eosinophils, macrophages, and T lymphocytes in mucosal biopsy specimens of patients with asthma and chronic bronchitis. J Allergy Clin Immunol 1999; 103: 563-73.
20. Cormican L, O'Sullivan S, Burke CM, Poulter LW. IFN-gamma but not IL-4 T cells of the asthmatic bronchial wall show increased incidence of apoptosis. Clin Exp Allergy 2001; 31: 731-9.
21. Lundy SK, S. P. Lerman, and D. L. Boros. Soluble egg antigen-stimulated T helper lymphocyte apoptosis and evidence for cell death mediated by FasL+ T and B cells during Schistosoma mansoni infection. Infection and Immunity 2001; 69: 271-280.
22. Lundy SK, Boros DL. Fas ligand-expressing B-1a lymphocytes mediate CD4(+)-T-cell apoptosis during schistosomal infection: induction by interleukin 4 (IL-4) and IL-10. Infect Immun 2002; 70: 812-9.
23. Kantor AB. The development and repertoire of B-1 cells (CD5 B cells). Immunol Today 1991; 12: 389-91.
24. Hardy RR, Hayakawa K. B cell development pathways. Annu Rev Immunol 2001; 19: 595-621.
25. Fagarasan S, Honjo T. T-Independent immune response: new aspects of B cell biology. Science 2000; 290: 89-92.
26. Velupillai P, Harn DA. Oligosaccharide-specific induction of interleukin 10 production by B220+ cells from schistosome-infected mice: a mechanism for regulation of CD4+ T-cell subsets. Proc Natl Acad Sci U S A 1994; 91: 18-22.
27. Velupillai P, Sypek J, Harn DA. Interleukin-12 and -10 and gamma interferon regulate polyclonal and ligand-specific expansion of murine B-1 cells. Infect Immun 1996; 64: 4557-60.
28. Velupillai P, Secor WE, Horauf AM, Harn DA. B-1 cell (CD5+B220+) outgrowth in murine schistosomiasis is genetically restricted and is largely due to activation by polylactosamine sugars. J Immunol 1997; 158: 338-44.
29. Sprent J, Bruce J, Ron Y, Webb SR. Physiology of B cells in mice with X-linked immunodeficiency. I. Size, migratory properties, and turnover of the B cell pool. J Immunol 1985; 134: 1442-8.
30. Ohsugi Y, Gershwin ME, Ahmed A. Study of congenitally immunologic mutant New Zealand mice. V. B cell function of NZB-Xid mice. J Immunogenet 1981; 8: 129-37.
31. Scher I, Ahmed A, Strong DM, Steinberg AD, Paul WE. X-linked B-lymphocyte immune defect in CBA/HN mice. I. Studies of the function and composition of spleen cells. J Exp Med 1975; 141: 788-803.
32. Boswell HS, Nerenberg MI, Scher I, Singer A. Role of accessory cells in B cell activation. III. Cellular analysis of primary immune response deficits in CBA/N mice: presence of an accessory cell-B cell interaction defect. J Exp Med 1980; 152: 1194-309.
33. Huber BT, Tokuhisa T, Herzenberg LA. Primary and secondary in situ antibody response: abnormal affinity maturation pattern in mice carrying the xid gene. Eur J Immunol 1981; 11: 353-7.
34. Reale MA, Bona CA, Schulman JL. Isotype profiles of anti-influenza antibodies in mice bearing the xid defect. J Virol 1985; 53: 425-9.
35. Lebrun P, Sidman CL, Spiegelberg HL. IgE formation and Fc receptor-positive lymphocytes in normal, immuno-deficient, and auto-immune mice infected with Nippostrongylus brasiliensis. J Immunol 1988; 141: 249-57.
36. Gaubert S, Viana da Costa A, Maurage CA, Lima EC, Fontaine J, Lafitte S, et al. X-linked immunodeficiency affects the outcome of Schistosoma mansoni infection in the murine model. Parasite Immunol 1999; 21: 89-101.
37. Kawakami Y, Kitaura J, Hata D, Yao L, Kawakami T. Functions of Bruton's tyrosine kinase in mast and B cells. J Leukoc Biol 1999; 65: 286-90.
38. Hata D, Kawakami Y, Inagaki N, Lantz CS, Kitamura T, Khan WN, et al. Involvement of Bruton's tyrosine kinase in FcepsilonRI-dependent mast cell degranulation and cytokine production. J Exp Med 1998; 187: 1235-47.
39. Setoguchi R, Kinashi T, Sagara H, Hirosawa K, Takatsu K. Defective degranulation and calcium mobilization of bone-marrow derived mast cells from Xid and Btk-deficient mice. Immunol Lett 1998; 64: 109-18.
40. Hoerauf A, Solbach W, Lohoff M, Rollinghoff M. The Xid defect determines an improved clinical course of murine leishmaniasis in susceptible mice. Int Immunol 1994; 6: 1117-24.
41. Minoprio P, el Cheikh MC, Murphy E, Hontebeyrie-Joskowicz M, Coffman R, Coutinho A, et al. Xid-associated resistance to experimental Chagas' disease is IFN-gamma dependent. J Immunol 1993; 151: 4200-8.
42. Teran LM, Noso N, Carroll M, Davies DE, Holgate S, Schroder JM. Eosinophil recruitment following allergen challenge is associated with the release of the chemokine RANTES into asthmatic airways. J Immunol 1996; 157: 1806-12.
43. Khan WN, Alt FW, Gerstein RM, Malynn BA, Larsson I, Rathbun G, et al. Defective B cell development and function in Btk-deficient mice. Immunity 1995; 3: 283-99.
44. Kerner JD, Appleby MW, Mohr RN, Chien S, Rawlings DJ. Maliszewski CR, et al. Impaired expansion of mouse B cell progenitors lacking Btk. Immunity 1995; 3: 301-12.
45. Hahne M, Renno T, Schroeter M, Irmler M, French L, Bornard T, et al. Activated B cells express functional Fas ligand. Eur J Immunol 1996; 26: 721-4.
46. Wolf SD, Dittel BN, Hardardottir F, Janeway CA, Jr. Experimental autoimmune encephalomyelitis induction in genetically B cell-deficient mice. J Exp Med 1996; 184: 2271-8.
47. Mizoguchi E, Mizoguchi A, Preffer FI, Bhan AK. Regulatory role of mature B cells in a murine model of inflammatory bowel disease. Int Immunol 2000; 12: 597-605.
48. Cheever AW, Byram JE, Hieny S, von Lichtenberg F, Lunde MN, Sher A. Immunopathology of Schistosoma japonicum and S. mansoni infection in B cell depleted mice. Parasite Immunol 1985; 7: 399-413.
49. Tian J, Zekzer D, Hanssen L, Lu Y, Olcott A, Kaufman DL. Lipopolysaccharide-activated B cells down-regulate Th1 immunity and prevent autoimmune diabetes in nonobese diabetic mice. J Immunol 2001; 167: 1081-9.
50. Minagawa R, Okano S, Tomita Y, Shimizu I, Iwai T, Kishihara K, et al. Role of Fas-Fas ligand interaction in donor-specific transfusion-induced tolerance to H-Y antigen. Transplant Proc 2001; 33: 283.
51. Mullauer L, Mosberger I, Chott A. Fas ligand expression in nodal non-Hodgkin's lymphoma. Mod Pathol 1998; 11: 369-75.
52. Nagafuchi H, Wakisaka S, Takeba Y, Takeno M, Sakane T, Suzuki N. Aberrant expression of Fas ligand on anti-DNA autoantibody secreting B lymphocytes in patients with systemic lupus erythematosus: "immune privilege"-like state of the autoreactive B cells. Clin Exp Rheumatol 2002; 20: 625-31.
53. Zoi-Toli O, Meijer CJ, Oudejans JJ, de Vries E, van Beek P, Willemze R. Expression of Fas and Fas ligand in cutaneous B-cell lymphomas. J Pathol 1999; 189: 533-8.